1.
Andersson J, Linderholm B, Greim G, Lindh B, Lindman H, Tennvall J, et al. A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in Sweden. AO [Internet]. 2002 Jan. 1 [cited 2026 May 23];41(3):276-81. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/26651